Peptide Central
The most common scam is not a fake product. It is a real product with less peptide in the vial than the label claims, and it is invisible without testing.
When people picture a peptide scam they picture an empty vial, or a vial of something else entirely. Those exist, but they are the crude end of the market and they get caught quickly, because they fail obviously.
The common cheat is underfilling, and it is nearly undetectable.
A vial labelled 10mg that contains 7mg of peptide looks identical, dissolves identically, and behaves identically. The buyer has no way to know. There is no sensory check that catches it. It survives contact with reality in a way that an empty vial does not, which is exactly why it is the dominant form of dishonesty in this industry.
Understanding this reframes the whole question of price.
Line up five vendors selling "BPC-157 10mg" and the prices can differ by a factor of four. The compound is the same. The label is the same. So what is actually varying?
As covered in our guide to reading a CoA, a "10mg" vial contains 10mg of lyophilised powder, not 10mg of peptide. The remainder is counterion (usually TFA), bound water, and residual salts. Net peptide content for a legitimate product typically lands around 70-85%.
A dishonest supplier simply fills less. Since almost no buyer asks for net peptide content, and almost no vendor volunteers it, this is close to a free lunch for the seller.
A vendor selling at 60% of the market price with 60% of the peptide in the vial is not cheaper. They are the same price, dishonestly.
Solid-phase peptide synthesis produces the target sequence plus a family of closely-related failures, mostly deletion sequences, where a coupling step missed a residue. Removing them takes chromatographic purification, and each pass costs money and loses yield.
Stopping at 95% instead of pushing to 99% is meaningfully cheaper to produce. This is a real and legitimate cost axis, and it is why purity grades exist.
Synthesis cost scales with length and with the awkwardness of the sequence. A 15-residue peptide is not the same manufacturing problem as a 39-residue one. Some sequences are simply harder, aggregation-prone stretches, difficult couplings, residues needing special protection.
This means cross-compound price comparisons tell you nothing. Retatrutide costing many times what BPC-157 costs is not a markup; it is a different molecule with a different synthesis.
Independent analytical testing costs real money per batch. A vendor testing every batch and publishing lab-direct results is carrying a cost that a vendor publishing a recycled PDF is not.
Domestic warehousing, a registered business entity, GST, consumer-law obligations, and an actual address you can send a complaint to are all costs. An anonymous operation with a crypto wallet has none of them.
Here is the most useful heuristic in this article.
Peptide synthesis has a real, physical cost floor. Raw material, synthesis, purification, lyophilisation, vialling, and testing cost what they cost. There is a price below which a vial cannot be honestly produced and sold at a profit.
When a vendor is priced dramatically below everyone else, there are only a few explanations, and none of them are good:
Nobody has a secret supply of cheap peptide. The synthesis houses are largely the same ones, selling to everyone, at roughly the same prices. A vendor claiming an enormous cost advantage over the entire rest of the market is telling you something is missing, and the missing thing is usually in the vial.
Suspiciously cheap should read to you exactly the way suspiciously cheap reads in any other market where the buyer cannot verify quality.
Documentation:
Business:
Behaviour:
If you only ask a supplier one thing, ask:
"What is the net peptide content of this batch, and can you send me the third-party CoA directly from the lab?"
A legitimate supplier has both answers ready. The response to this question, not the content of the answer, but how readily it comes, will tell you most of what you need to know.
Disclaimer: Provided for educational purposes relating to research quality assurance and supplier due diligence. All products are supplied strictly for in-vitro laboratory and research use, not for human consumption. Not medical advice.
A non-clinical reference on catalogue identity, analytical documentation and the limits of what published evidence and batch testing establish.
Research DocumentationA non-clinical reference on catalogue identity, analytical documentation and the limits of what published evidence and batch testing establish.
Site materials are supplied solely for non-clinical in-vitro laboratory research. They must not be used in or on humans or animals. We do not provide dosing, routes of administration, treatment, cosmetic-use or in-vivo guidance. Read the legal and research-use terms.
